Clinical

Dataset Information

0

Liver Transplantation for Non-Resectable Colorectal Liver Metastasis


ABSTRACT: The study aims to evaluate the efficacy of liver transplantation in the context of non-resectable colorectal liver metastasis. The primary endpoint is the overall survival in this group of patients while the secondary endpoint is the disease-free survival. Patients included in this protocol will be evaluated either for whole or partial liver transplantation from deceased or living donors. Type of different transplantations proposed are as follows: 1. Whole liver graft or partial liver (split) from a deceased donor 2. Partial liver graft retrieved from a deceased donor and orthotopically implanted after having performed a left hepatectomy in the recipient. 3. Partial liver graft retrieved from a deceased donor and heterotopically implanted if total hepatectomy can not be performed. 4. Partial liver graft retrieved from a living donor and orthotopically implanted after having performed total hepatectomy. 5. Partial liver graft retrieved from a living donor and orthotopically implanted after having after having performed a left hepatectomy in the recipient. 6. Partial liver graft retrieved from a living donor and heterotopically implanted if total hepatectomy can not be performed. In cases 2-3-5-6 total hepatectomy of native liver can be secondarily performed after having achieved a proper graft hypertrophy in order to avoid a small for size syndrome

DISEASE(S): Neoplasm Metastasis,Liver Metastasis Colon Cancer,Colorectal Cancer,Liver Neoplasms

PROVIDER: 2400483 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

Similar Datasets

| 2270149 | ecrin-mdr-crc
2010-12-18 | E-GEOD-26138 | biostudies-arrayexpress
2014-02-05 | E-GEOD-54673 | biostudies-arrayexpress
2020-07-01 | GSE77888 | GEO
2024-06-21 | MSV000095107 | MassIVE
2014-07-03 | E-GEOD-59023 | biostudies-arrayexpress
2014-02-28 | GSE55434 | GEO
2009-05-01 | GSE13864 | GEO
2022-12-30 | GSE188742 | GEO
2010-11-01 | GSE22879 | GEO